Home

Oral Solid Dose Regulatory Approval Update
CDER has approved 33 novel drugs so far, almost half of which are oral solid dose formulations. read more
Root Cause Analysis of Tablet Manufacturing Issues
Many formulation challenges such as poor flow, segregation, capping and weak tablets can be traced to suboptimal micromeritics properties. read more
Creating Amorphous Solid Dispersions via Spray Drying
Spray-dried ASDs are increasingly used to improve bioavailability for complex new molecules, making efficient process development tools and methodologies essential for accelerating commercialization. read more
When AI Isn't Enough
While AI offers significant advantages in data processing and analytical capability, its use in regulated industries must be carefully governed. Organizations must balance innovation with compliance by ensuring robust data integrity practices, appropriate validation and ongoing human oversight. read more

CPHI Milan Pharma Awards 2026 Finalists Announced
September 16, 2026
The CPHI Pharma Awards has categories for drug development, digital transformation, supply chain, manufacturing, sustainability, partnerships, and leadership. read more
Definium Psychedelic ODT Scores Another Trial Win
September 15, 2026
This is the company’s third positive phase 3 readout for its DT120 orally disintegrating tablet. read more
Newly-Approved AstraZeneca Pill Fails Late-Stage Breast Cancer Trial
September 14, 2026
Etcamah didn't meet the primary endpoint of progression-free survival in patients with ER-positive, HER2-negative advanced breast cancer. read more